104 related articles for article (PubMed ID: 24973679)
1. Mutational signatures in Helicobacter pylori-induced gastric cancer: lessons from new sequencing technologies.
Derks S; Bass AJ
Gastroenterology; 2014 Aug; 147(2):267-9. PubMed ID: 24973679
[No Abstract] [Full Text] [Related]
2. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis.
Valenzuela MA; Canales J; Corvalán AH; Quest AF
World J Gastroenterol; 2015 Dec; 21(45):12742-56. PubMed ID: 26668499
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA alterations in the progression of gastric carcinomas: unexplored issues and future research needs.
Rigoli L; Caruso RA
World J Gastroenterol; 2014 Nov; 20(43):16159-66. PubMed ID: 25473169
[TBL] [Abstract][Full Text] [Related]
5. [Helicobacter pylori spectrum: from gastritis to malignancy].
Stolte M
Leber Magen Darm; 1992 May; 22(3):91-4. PubMed ID: 1625512
[No Abstract] [Full Text] [Related]
6. Comprehensive Integration of Genome-Wide Association and Gene Expression Studies Reveals Novel Gene Signatures and Potential Therapeutic Targets for
Badr MT; Omar M; Häcker G
Front Immunol; 2021; 12():624117. PubMed ID: 33717131
[No Abstract] [Full Text] [Related]
7. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection.
Park SY; Yoo EJ; Cho NY; Kim N; Kang GH
J Pathol; 2009 Dec; 219(4):410-6. PubMed ID: 19639607
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of IL-1β and TNF-α polymorphisms on the H. pylori-related gastric pre-malignant condition.
Tahara T; Shibata T; Yamashita H; Yoshioka D; Okubo M; Yonemura J; Kamiya Y; Ishizuka T; Nakagawa Y; Nagasaka M; Iwata M; Nakamura M; Hirata I; Arisawa T
Hepatogastroenterology; 2012; 59(120):2416-20. PubMed ID: 23169178
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori infection affects the expression of PCNA, p53, c-erbB-2 and Bcl-2 in the human gastric mucosa.
Jorge O; Cuello Carrión FD; Jorge A; Ciocca DR
Rev Esp Enferm Dig; 2003 Feb; 95(2):97-104, 89-96. PubMed ID: 12760717
[TBL] [Abstract][Full Text] [Related]
10. [Helicobacter pylori infection: a facilitator of stomach cancer?].
Cooreman MP; Malfertheiner P
Z Gastroenterol Verh; 1991 Mar; 26():284-6. PubMed ID: 1714176
[No Abstract] [Full Text] [Related]
11. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms associated with aggressiveness of alpha-fetoprotein-positive gastric cancer.
Kountouras J; Zavos C; Chatzopoulos D; Katsinelos P
Hepatogastroenterology; 2007 Mar; 54(74):329-30. PubMed ID: 17523267
[No Abstract] [Full Text] [Related]
13. Helicobacter pylori and mucosa-associated lymphoid tissue: what's new.
Kuo SH; Cheng AL
Hematology Am Soc Hematol Educ Program; 2013; 2013():109-17. PubMed ID: 24319171
[TBL] [Abstract][Full Text] [Related]
14. Downregulated Expression of E-cadherin and TP53 in Patients with Gastric Diseases: the Involvement of H. pylori Infection and Its Virulence Markers.
Ferraz MA; Zabaglia LM; Pereira WN; Orcini WA; de Labio RW; Caleman Neto A; Wisnieski F; Calcagno DQ; Santos LC; Assumpção PP; Burbano RR; Artigiani R; Smith Mde A; Payão SL; Rasmussen LT
J Gastrointest Cancer; 2016 Mar; 47(1):20-6. PubMed ID: 26585943
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the risk for gastric cancer using candidate methylation markers in the non-neoplastic gastric mucosae.
Shin CM; Kim N; Park JH; Kang GH; Kim JS; Jung HC; Song IS
J Pathol; 2012 Mar; 226(4):654-65. PubMed ID: 22252584
[TBL] [Abstract][Full Text] [Related]
16. Changes of gene expression in gastric preneoplasia following Helicobacter pylori eradication therapy.
Tsai CJ; Herrera-Goepfert R; Tibshirani RJ; Yang S; Mohar A; Guarner J; Parsonnet J
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):272-80. PubMed ID: 16492915
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutation of mitochondrial DNA in Helicobacter pylori-associated chronic gastritis in patients with and without gastric cancer.
Hiyama T; Tanaka S; Shima H; Kose K; Kitadai Y; Ito M; Sumii M; Yoshihara M; Shimamoto F; Haruma K; Chayama K
Int J Mol Med; 2003 Aug; 12(2):169-74. PubMed ID: 12851712
[TBL] [Abstract][Full Text] [Related]
18. Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis.
Soutto M; Romero-Gallo J; Krishna U; Piazuelo MB; Washington MK; Belkhiri A; Peek RM; El-Rifai W
Oncotarget; 2015 Jul; 6(20):17911-22. PubMed ID: 25980439
[TBL] [Abstract][Full Text] [Related]
19. Low presence of p53 abnormalities in H pylori-infected gastric mucosa and in gastric adenocarcinoma.
Berloco P; Russo F; Cariola F; Gentile M; Giorgio P; Caruso ML; Valentini AM; Di Matteo G; Di Leo A
J Gastroenterol; 2003; 38(1):28-36. PubMed ID: 12560919
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori induces promoter hypermethylation and downregulates gene expression of IRX1 transcription factor on human gastric mucosa.
Guo XB; Guo L; Zhi QM; Ji J; Jiang JL; Zhang RJ; Zhang JN; Zhang J; Chen XH; Cai Q; Li JF; Yan M; Gu QL; Liu BY; Zhu ZG; Yu YY
J Gastroenterol Hepatol; 2011 Nov; 26(11):1685-90. PubMed ID: 21649733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
